The California Division of Workers’ Compensation’s Pharmacy and Therapeutics Committee is meeting virtually from 12:30-2:30 p.m. Jan. 18.
Members of the committee that advises the DWC on evidence-based changes to its prescription drug formulary will deliberate on coverage for items including artificial tears, topical analgesics and topical lidocaine.
Committee members will also review drug listings in the Medical Treatment Utilization Schedule.
And they will discuss the Inflation Reduction Act of 2022. The federal law enacted by President Biden in August includes sever...
Comments